The proliferative fingerprint also correlated with tumor mutation burden (P = 0.016) and MLH1 methylation (P = 0.0071), consistent with the association between tumor cell proliferation and MMR deficiency in cohorts 1 and 2. The gene discussed is MLH1; the disease is neoplasm.